Clinical trial
Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia.
NCT01027624 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia.
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- April 30, 2010
- Enrollment
- 3,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
undertreatment of hypercholesterolaemia